Meanwhile, recombinant DNase I was successfully explored in preclinical studies as thrombolytic agent to target elevated levels of extracellular DNA, likely released as NETs, after ischemic stroke [10,11,13,72,73]. Here, DNASE1 is linked to ischemic stroke.